Did I mention that ELTP 2 bead pharma-based ADF is modular across every agonist and time-release characteristic? Are you starting to understand what I mean when I say The Golden Ticket? They aren't just giving these ADF labels away. And when SequestOx is approved with ADF label, FDA is on record saying that there will be no new generic oxycodone approved without ADF and all existing oxycodone ANDA's are on notice that they could be pulled unless they acquire equivalent ADF. Did I mention ELTP 2 bead pharma-based ADF is fully-licensable?
What happens when PuraCap Pharmaceuticals voluntarily adds ADF to their oxycodone ANDA by utilizing ELTP 2 bead pharma-based ADF? Then there would be 2 immediate-release oxycodone ADF. Add a hardshell ADF and gooey ADF and pretty soon you've got the makings of a non-ADF generic oxy flush-out.
Now repeat with immediate-release hydrocodone, morphine, hydromorphone. It's too easy. I'd license out the 12 & 24 hours products and pile up the quick & dirty (and cheap) immediate-release NDA's. (One caveat being there is not currently stand alone hydrocodone IR, only combos with acetaminophen,etc. so no 505b2 on that one.)
Nice piece of DD you got there WeeZuhl, impressive graphs once eli200 is approved its pretty simple to use their plugg'n'play tech to every opioid out there. Or licence it out Few months away from nasdaq and serious investors Can you repost these graphs on kempharms board? Kempharm was 50% institutional owned LOL LOL Its gonna be intresting to see where 50% institutional ownership will take us pricewise